vimarsana.com
Home
Live Updates
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 G
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 G
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA
YANTAI, China, Dec. 27, 2023 /PRNewswire/ -- Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the
Related Keywords
China ,
Thailand ,
United States ,
Japan ,
Yantai ,
Shandong ,
Dou Changlin ,
International Agency For Research On Cancer ,
Drug Administration ,
Bispecific Engager Technology Platform ,
Phage Display Technology Platform ,
Technology Platform ,
World Health Organization ,
Boan Biotech ,
Orphan Drug Designation ,
Antibody Drug Conjugate ,
International Agency ,
Chief Operating Officer ,
Nivolumab Injection ,
Human Antibody Transgenic Mouse ,
Bispecifict Cell Engager Technology Platform ,
Cell Therapy ,
Pancreatic Cancer Worldwide ,
Two Innovative Drugs Targeting Claudin ,
Thailand Business ,